2018
Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease
Pokharel Y, Jones PG, Graham G, Collins T, Regensteiner JG, Murphy TP, Cohen D, Spertus JA, Smolderen K. Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease. Circulation Cardiovascular Quality And Outcomes 2018, 11: e004157. PMID: 29643064, PMCID: PMC5901766, DOI: 10.1161/circoutcomes.117.004157.Peer-Reviewed Original ResearchBlack or African AmericanCanadaEndovascular ProceduresExercise TherapyExercise ToleranceFemaleHealth Status DisparitiesHumansIntermittent ClaudicationMaleMiddle AgedPeripheral Arterial DiseaseQuality of LifeRecovery of FunctionSurveys and QuestionnairesTime FactorsTreatment OutcomeUnited StatesWalk TestWhite People
2010
One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry
Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, Mahoney EM, investigators O. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry. Canadian Journal Of Cardiology 2010, 26: e297-e305. PMID: 20931098, PMCID: PMC2954538, DOI: 10.1016/s0828-282x(10)70437-2.Peer-Reviewed Original ResearchConceptsPeripheral arterial diseaseContinued Health (REACH) RegistryReduction of AtherothrombosisCardiovascular risk factorsCoronary artery diseaseArterial bedMedication useHospitalization costsAtherothrombotic diseaseArtery diseaseMedication costsCerebrovascular diseaseHealth registriesRisk factorsEconomic burdenMore cardiovascular risk factorsAnnual hospitalization costsCardiovascular-related hospitalizationsMean hospitalization costOne-year followOne-year costsCardiovascular eventsPolyvascular diseaseAnnual hospitalizationsClinical factors